Supplements

Fenavari (combined standardized extract of fenugreek and shatavari) significantly reduces menopausal symptoms and improves sleep quality in women aged 40-60 years

In a randomized, double-blind, placebo-controlled trial, 138 women with menopausal symptoms received Fenavari 300 mg, Fenavari 500 mg, or placebo daily for 84 days. Both doses significantly reduced Menopause Rating Scale (MRS) total scores from Day 14 onward, with the 500 mg dose showing greater effects (MRS change: -10.40 vs -8.26 for 300 mg vs -4.09 for placebo). Significant improvements were also observed in sleep quality, anxiety, mood, and hormonal parameters (increased estradiol, decreased FSH).

Last updated: Aug 5, 2026โ€ข1 RCTsโ€ข๐Ÿ“– Read as article โ†’

Evidence Score

Evidence Score44/100
Human RCTโ˜…โ˜…โ˜†โ˜†โ˜†
Meta-analysisโ˜†โ˜†โ˜†โ˜†โ˜†
Mechanismโ˜…โ˜…โ˜…โ˜…โ˜…
Safetyโ˜…โ˜…โ˜…โ˜…โ˜†
Confidencelow

Study Evidence

Study 1. Dose-Dependent Efficacy of a Combined Standardized Extract of Fenugreek and Shatavari on Menopausal Symptoms: A Randomized, Double-Blind, Parallel, Placebo-Controlled Study.

observational

Kashinath RN, Bhat VV, Morde A, Joshua L, Thomas JV ยท Women's health reports (New Rochelle, N.Y.) (2026)

Participants: N/A
Duration: 84 days
Intervention: Fenavari (standardized extract of Asparagus racemosus and Trigonella foenum-graecum) at doses of 300 mg or 500 mg once daily for 84 days
Outcome: Menopause Rating Scale (MRS) total score, Pittsburgh Sleep Quality Index (PSQI), Profile of Mood States, Beck Anxiety Inventory, serum estradiol, progesterone, FSH
Effect Size: MRS total score change: -8.26 (300 mg), -10.40 (500 mg) vs -4.09 (placebo); p < 0.0001
Population: Women aged 40-60 years with menopausal symptoms

Result:

Mechanism Graph

Fenavari contains phytoestrogens from fenugreek and shatavari
โ†“
Phytoestrogens bind to estrogen receptors, mimicking estrogen action
โ†“
This leads to increased serum estradiol and reduced FSH levels
โ†“
Result: alleviation of menopausal symptoms and improved sleep, mood, and anxiety

Limitations

  • โš Study duration was only 84 days; long-term efficacy and safety not assessed
  • โš No comparison with hormone replacement therapy or other standard treatments
  • โš Potential industry bias as the study may have been funded by the manufacturer
  • โš No data on adherence or dropout reasons beyond completion rates

Frequently Asked Questions

What is Fenavari?โ–ผ

Fenavari is a novel formulation combining standardized extracts of Asparagus racemosus (shatavari) and Trigonella foenum-graecum (fenugreek), used as a nonhormonal option for menopausal symptom relief.

How quickly does Fenavari work for menopausal symptoms?โ–ผ

Significant reductions in Menopause Rating Scale scores were observed from Day 14 of treatment, with continued improvement through Day 84.

Does Fenavari improve sleep quality?โ–ผ

Yes, the study reported significant improvements in sleep quality as measured by the Pittsburgh Sleep Quality Index by Day 84 compared to placebo.

What dose of Fenavari is recommended?โ–ผ

The study tested 300 mg and 500 mg daily; the 500 mg dose showed earlier and greater effects, suggesting it may be more effective.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Kashinath RN, Bhat VV, Morde A, Joshua L, Thomas JV. "Dose-Dependent Efficacy of a Combined Standardized Extract of Fenugreek and Shatavari on Menopausal Symptoms: A Randomized, Double-Blind, Parallel, Placebo-Controlled Study.." Women's health reports (New Rochelle, N.Y.), 2026. PMID: 42539366 DOI: 10.1177/26884844261465161
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.